Shifting Trends in the Causative Mycobacterial Agents of Urinary Tract Infection and their Sensitivity Pattern on Antibiograms in Female Diabetic Patients
DOI:
https://doi.org/10.52206/jsmc.2025.15.2.1046Abstract
Background: It is important to avoid using broad spectrum therapy for Urinary Tract Infections as it can contribute to drug resistance. A quick analysis of causative agent and their antibiograms is necessary for cost effective empirical therapy.
Objectives: To determine the bacteria profile in urine sample of Urinary Tract Infections in diabetics and to determine the antibiotic susceptibility and sensitivity patterns of those bacteria.
Materials and Methods: It was a descriptive type of cross sectional study conducted in of Bacha Khan Medical Complex Swabi for 3 months.
Results: A total of 280 samples were collected from the microbiology lab. Out of which 234 were E. coli (83.6%), 16 were Klebsiella Pneumonia (5.7%), 13 were Proteus Mirabilis (4.6%), 10 were Pseudomonas (3.6%), 7 were Enterococcus faecalis (2.5%). Resistance was found for Amoxicillin+clauvulanic acid and Ciprofloxacin, while the organisms were found to be highly sensitive to Ertapenem, Meropenem, Imipenem and 100% sensitive to vancomycin.
Conclusion: The most dominant organism was E.coli in culture and sensitivity reports followed by Klebsiella pneumonia then Proteus mirabilis, Pseudomonas and Enterococcus faecalis. Among antibiotics ciprofloxacin and amoxicillin showed least sensitivity in Urinary Tract Infections patients with diabetes and most effective antibiotics in the previous researches (doxycycline and cefepime) also showed alarmingly less sensitivity to uropathogens found in diabetics. The thing that stood out was that all these pathogens were highly sensitive to Imipenem, Meropenem, Ertapenem and Vancomycin.
Keywords: Diabetes Mellitus, Resistance, Sensitivity, Urinary Tract Infections (UTI), Uropathogen.
References
Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary tract infections: the current scenario and future prospects. Pathogens. 2023 Apr 20;12(4):623. https://doi.org/10.3390/pathogens12040623
Trze?niewska-Ofiara Z, Mendrycka M, Wo?niak- Kosek A. Urinary tract infections: epidemiological and clinical aspects. Medical Studies/Studia Medyczne. 2024 Apr 1;40(2):208-15. https://doi.org/10.5114/ms.2024.140982
Silva A, Costa E, Freitas A, Almeida A. Revisiting the frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections. Antibiotics (Basel). 2022;11(6):768. https://doi.org/10.3390/antibiotics11060768
Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary tract infections: the current scenario and future prospects. Pathogens. 2023;12(4):623. https://doi.org/10.3390/pathogens12040623
Gebretensaie Y, Atnafu A, Girma S, Alemu Y, Desta K. Prevalence of Bacterial Urinary Tract Infection, Associated Risk Factors, and Antimicrobial Resistance Pattern in Addis Ababa, Ethiopia: A Cross-Sectional Study. Infect Drug Resist. 2023 May 16;16:3041-3050. https://doi.org/10.2147/IDR.S402279
Kang TB, Hisham Y, Lee Y, Jhun H, Kim J, Kim S. Diabetes and bacterial infection. International Journal of Clinical Endocrinology and Metabolism. 2022 Sep 24;8(1):001-8. https://doi.org/10.17352/ijcem.000054
Yasmeen BN, Islam S, Islam S, Uddin MM, Jahan R. Prevalence of urinary tract infection, its causative agents, and antibiotic sensitivity pattern: A study in Northern International Medical College Hospital, Dhaka. North Int Med Coll J. 2015;7(1):105–9. https://doi.org/10.3329/nimcj.v7i1.25704
Yenehun WG, Belete AY, Erku AW. Prevalence of Bacterial Urinary Tract Infection and Antimicrobial Susceptibility Patterns Among Diabetes Mellitus Patients Attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Infect Drug Resist. 2021 Apr 15;14:1441-1454. https://doi.org/10.2147/IDR.S298176.
Ahmad S, Hussain A, Khan MS, Shakireen N, Ali I. Diabetes mellitus and urinary tract infection: Causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status. Pakistan Journal of Medical Sciences. 2020 Nov;36(7):1550. https://doi.org/10.12669/pjms.36.7.2881
McCowan C, Bakhshi A, McConnachie A, Malcolm W, Barry SJ, Santiago VH, et al. E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community. BMC infectious diseases. 2022 Oct 28;22(1):805.
Woldemariam HK, Geleta DA, Tulu KD. Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. BMC Infect Dis. 2019;19(1):43. https://doi.org/10.1186/s12879-018-3669-5
Nauclér P, Huttner A, van Werkhoven CH, Singer M, Tattevin P, Einav S, et al. Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect. 2021 Feb;27(2):175-181. https://doi.org/10.1016/j.cmi.2020.02.032
Shallcross L, Rockenschaub P, Blackburn R, Nazareth I, Freemantle N, Hayward A. Antibiotic prescribing for lower UTI in elderly patients in primary care and risk of bloodstream infection: A cohort study using electronic health records in England. PLoS Med. 2020 Sep 21;17(9):e1003336. https://doi.org/10.1371/journal.pmed.1003336
Morel CM, de Kraker MEA, Harbarth S. Enhanced Surveillance Expert Consensus Group (CANSORT- SCI). Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options. Front Med (Lausanne). 2021 Apr 19;8:652638. https://doi.org/10.3389/fmed.2021.652638
Torumkuney D, Kundu S, Vu GV, Nguyen HA, Pham HV, Kamble P, et al. Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome. J Antimicrob Chemother. 2022 Sep 6;77(Suppl_1):i26-i34. https://doi.org/10.1093/jac/dkac214
Truong WR, Hidayat L, Bolaris MA, Nguyen L, Yamaki J. The antibiogram: key considerations for its development and utilization. JAC Antimicrob Resist. 2021 May 25;3(2):dlab060. https://doi.org/10.1093/jacamr/dlab060
Gutema T, Weldegebreal F, Marami D, Teklemariam Z. Prevalence, Antimicrobial Susceptibility Pattern, and Associated Factors of Urinary Tract Infections among Adult Diabetic Patients at Metu Karl Heinz Referral Hospital, Southwest Ethiopia. Int J Microbiol. 2018 Nov 1;2018:7591259. https://doi.org/10.1155/2018/7591259
Aamir AH, Raja UY, Asghar A, Mahar SA, Ghaffar T, Ahmed I, et al. Asymptomatic urinary tract infections and associated risk factors in Pakistani Muslim type 2 diabetic patients. BMC Infect Dis. 2021 Apr 26;21(1):388. https://doi.org/10.1186/s12879-021-06106-7.
Czajkowski K, Bro?-Konopielko M, Teliga- Czajkowska J. Urinary tract infection in women. Prz Menopauzalny. 2021 Apr;20(1):40-47. https://doi.org/10.5114/pm.2021.105382
Ahmad S, Ali F, Qureshi SA, Uzma B, Shakeela Q, Sabir MS, et al. The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar. Pak J Pharm Sci. 2022 May;35(3(Special)):897-903. PMID: 35791585.
Teng J, Imani S, Zhou A, Zhao Y, Du L, Deng S, et al. Combatting resistance: Understanding multi-drug resistant pathogens in intensive care units. Biomed Pharmacother. 2023 Nov;167:115564. https://doi.org/10.1016/j.biopha.2023.115564.
Shaikh SM, Tiwari S, Purandare VB, Bhalekar P, Bhake R, Patil NB, et al. Clinico-Microbiological Profile of Urinary Tract Infections in Patients with Type 2 Diabetes: A Study Based in a Hospital Dedicated to Diabetes Care. Chronicle of Diabetes Research and Practice. 2025 Jan 1;4(1):26-30. https://doi.org/10.4103/cdrp.cdrp_10_24
Hamadalneel YB, Ahmed HO, Alamin MF, Almahy WM, Almustafa ZM, Yousif YM, et al. Prevalence and Antimicrobial Sensitivity Patterns of Uropathogens in Wad Medani, Sudan: A Three Years, Cross-Sectional Study. Infect Drug Resist. 2024 May 28;17:2131-2140. https://doi.org/10.2147/IDR.S464501. PMID: 38828377; PMCID: PMC11143980.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
